Growth & profitability
- Revenue has grown 155.8% per year over the past 5 years.
- Operating margin has expanded, at -23.1% in the latest year.
Financial health
- Total debt has grown slower than revenue (-43.4% vs 155.8% per year).
15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2026 | $66M | -$9M | 0.0% | -23.1% | — | — | $3M |
| 2025 | $78M | $4M | 0.0% | 10.1% | — | — | $14M |
| 2024 | $49M | -$21M | 0.0% | -32.0% | -$12M | — | $5M |
| 2023 | $68M | -$10M | 0.0% | -13.1% | -$10M | — | $7M |
| 2022 | $56M | $2M | 98.5% | -1.7% | $5M | — | $13M |
| 2021 | $600000 | -$63M | 0.0% | -2245.5% | -$26M | — | $17M |
| 2020 | $1M | -$15M | 0.0% | -310.6% | — | $11M | $14M |
| 2019 | — | -$16M | — | — | — | $62M | $18M |
| 2018 | — | -$18M | — | — | — | $62M | $18M |
| 2017 | — | -$15M | — | — | — | $68M | $13M |
| 2016 | — | -$42M | — | — | — | $199M | $25M |
| 2015 | — | -$31M | — | — | — | $197M | $25M |
| 2014 | — | -$26M | — | — | — | — | $50M |
| 2013 | — | -$21M | — | — | — | $203M | $13M |
| 2012 | — | -$23M | — | — | — | $223M | $18M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $26M | — | 0.0% | -20.7% | — | — | $3M |
| Dec '25 | $16M | -$875000 | 0.0% | -4.0% | — | — | $2M |
| Sep '25 | $12M | -$6M | 0.0% | -43.8% | — | — | $2M |
| Jun '25 | $11M | -$4M | 0.0% | -33.3% | — | — | $2M |
| Mar '25 | $16M | — | 0.0% | 13.7% | — | — | $14M |
| Dec '24 | $41M | $7M | 0.0% | 23.2% | — | — | $6M |
| Sep '24 | $13M | -$1M | 0.0% | -6.8% | — | — | $2M |
| Jun '24 | $9M | -$3M | 0.0% | -30.4% | — | — | $4M |
| Mar '24 | $10M | — | 0.0% | -141.9% | — | — | $5M |
| Dec '23 | $13M | -$3M | 0.0% | 3.2% | — | — | $6M |
| Sep '23 | $13M | -$317000 | 0.0% | 4.5% | — | — | $9M |
| Jun '23 | $13M | -$4M | 0.0% | -20.9% | — | — | $12M |
| Mar '23 | $13M | — | 0.0% | -20.8% | -$1M | — | $7M |
| Dec '22 | $28M | $5M | 0.0% | 12.3% | -$2M | — | $9M |
| Sep '22 | $14M | -$6M | 0.0% | -33.6% | -$5M | — | $10M |
| Jun '22 | $14M | -$6M | 0.0% | -33.7% | -$1M | — | $12M |
| Mar '22 | — | -$2M | — | — | $109000 | — | $13M |
| Dec '21 | — | -$408000 | — | — | -$5M | — | $20M |
| Sep '21 | $2M | -$184000 | 0.0% | -64.3% | $6M | — | $13M |
| Jun '21 | $6M | $5M | 0.0% | 49.5% | $4M | — | $13M |
How the market has priced CNVS against its own fundamentals since 2023-05 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Cineverse Corp.'s revenue has grown 155.8% per year. These are computed facts, not advice.
As of FY2026, Cineverse Corp. reported — of total debt against $3M of cash.
In FY2026, gross margin was —, operating margin -23.1%, and net margin -13.2%.
As of Jun '26, Cineverse Corp. traded at a price-to-earnings ratio of about 18.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.